| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |